Oruka Therapeutics (ORKA) Total Current Liabilities (2010 - 2026)
Oruka Therapeutics (ORKA) posted quarterly Total Current Liabilities of $16.6 million for Q1 2026, up 41.88% year-over-year from $11.7 million in Q1 2025, and up 8.19% quarter-over-quarter from $15.4 million in Q4 2025.
Oruka Therapeutics (ORKA) Total Current Liabilities (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $16.6 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 41.88% year-over-year to $16.6 million; the TTM figure through Mar 2026 stood at $16.6 million (up 41.88% YoY), while the FY2025 annual figure was $15.4 million, up 17.87% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $16.6 million, up from $15.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $21.0 million in Q3 2025, with the low at $637000.0 in Q4 2023.
- The 5-year median for Total Current Liabilities is $2.7 million (2022), against an average of $7.3 million.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities tumbled 67.64% in 2022, then surged 1947.57% in 2024.
- Oruka Therapeutics' Total Current Liabilities stood at $1.1 million in 2022, then plunged by 43.73% to $637000.0 in 2023, then soared by 1947.57% to $13.0 million in 2024, then grew by 17.87% to $15.4 million in 2025, then climbed by 8.19% to $16.6 million in 2026.
- Business Quant data shows ORKA's Total Current Liabilities at $16.6 million in Q1 2026, $15.4 million in Q4 2025, and $21.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Oruka Therapeutics | 6.98 Bn | 5.25 Bn | - | 22.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.97 Mn |
| Mar 31, 2026 | 16.63 Mn |
| Dec 31, 2025 | 15.37 Mn |
| Sep 30, 2025 | 20.97 Mn |
| Jun 30, 2025 | 12.11 Mn |
| Mar 31, 2025 | 11.72 Mn |
| Dec 31, 2024 | 13.04 Mn |
| Sep 30, 2024 | 18.04 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 1.58 Mn |
| Dec 31, 2023 | 637,000.00 |
| Sep 30, 2023 | 992,000.00 |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.94 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 2.72 Mn |
| Dec 31, 2021 | 3.50 Mn |
| Sep 30, 2021 | 3.18 Mn |